Aytac_2004_Curr.Drug.Targets.Immune.Endocr.Metabol.Disord_4_11

Reference

Title : CD26\/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy - Aytac_2004_Curr.Drug.Targets.Immune.Endocr.Metabol.Disord_4_11
Author(s) : Aytac U , Dang NH
Ref : Curr Drug Targets Immune Endocr Metabol Disord , 4 :11 , 2004
Abstract : Aytac_2004_Curr.Drug.Targets.Immune.Endocr.Metabol.Disord_4_11
ESTHER : Aytac_2004_Curr.Drug.Targets.Immune.Endocr.Metabol.Disord_4_11
PubMedSearch : Aytac_2004_Curr.Drug.Targets.Immune.Endocr.Metabol.Disord_4_11
PubMedID: 15032621

Related information

Citations formats

Aytac U, Dang NH (2004)
CD26\/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy
Curr Drug Targets Immune Endocr Metabol Disord 4 :11

Aytac U, Dang NH (2004)
Curr Drug Targets Immune Endocr Metabol Disord 4 :11